George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
George Adel, Product Specialist at EVER Pharma (Africa), shared on LinkedIn:
”When you position yourself as a scientific resource rather than just a representative, you don’t just participate in the market you help shape it.
Today at El Mabara Hospital, it was all about partnering with the ICU team to elevate stroke management.
By aligning the clinical benefits of Cerebrolysin (right regimen) with the latest global guidelines, we aren’t just discussing a product, we are actively driving market growth and helping doctors optimize patient recovery.
A sincere thank you to Dr. Peter Wadie for always challenging me to grow and giving me the professional backing to execute these steps.
And to Dr. Sally Moheb, thank you for your encouragement and for always believing in my vision it really drives me to keep growing.”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 14:26Why Factor XI Deficiency Deserves Greater Awareness – Haemophilia Foundation Australia
-
Jul 6, 2026, 14:17Yoon-Sik Kang: Low-Blood-Loss Hernia Repair Aims to Reduce Perioperative Risk
-
Jul 6, 2026, 14:14Soledad Molnar: Global Practice Patterns in Pregnancy-Associated Thromboprophylaxis
-
Jul 6, 2026, 13:53Ney Carter Borges: Bempedoic Acid Shows a Promising VTE Signal in CLEAR Outcomes Analysis
-
Jul 6, 2026, 13:37Rachad Zayat: Acute PE Study Finds USAT Associated With Better In-Hospital Outcomes
-
Jul 6, 2026, 13:28Inna Vilshanivska: Sharing Ukraine’s Experience in Blood Donor Retention at the ISBT 2026
-
Jul 6, 2026, 13:10Arun V. J.: Did You Know A Glass Of Water is The Best Way To Retain A Blood Donor?
-
Jul 6, 2026, 13:10Javed Anees: The Hidden Power of Biotin in Modern Medicine
-
Jul 6, 2026, 12:46Saneha Anjum Shaikh: Red Cell Aliquoting – Precision in Transfusion Medicine